Tumors not evaluated for pSTAT3Y705 due to missing tissue had more favorable tumor characteristics and were less often of the lobular type, and patients with such tumors were more likely to have been treated with aromatase inhibitors than patients with evaluable tumors. This evidence concerns the gene CYP19A1 and neoplasm.